Cocrystal Pharma, Inc. (COCP) stock
COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.98−0.03 (-3.28%)
Close on Nov 18, 2026Market cap $18.82MP/E –Yield –
Cocrystal Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cocrystal Pharma's revenue for the twelve months ending Dec 31, 2020 was $2.01M, down 69.3% year over year. For fiscal 2020 it was $2.01M, down 69.3% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $2.01M | -69.3% |
| FY2019 | Dec 31, 2019 | $6.56M | -48.4% |
| FY2011 | Dec 31, 2011 | $12.71M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $105.00K | -81.0% |
| Q1 FY2026 | Mar 31, 2026 | $225.00K | -51.2% |
| Q4 FY2020 | Dec 31, 2020 | $510.00K | +26.9% |
| Q3 FY2020 | Sep 30, 2020 | $489.00K | -0.6% |
| Q2 FY2020 | Jun 30, 2020 | $554.00K | -6.4% |
| Q1 FY2020 | Mar 31, 2020 | $461.00K | -90.9% |
| Q4 FY2019 | Dec 31, 2019 | $402.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $492.00K | – |
| Q2 FY2019 | Jun 30, 2019 | $592.00K | – |
| Q1 FY2019 | Mar 31, 2019 | $5.08M | – |
See a number that looks wrong?